Table 2. Treatment administered to the study population (N=872).
| Characteristics | N (%) | p | |
|---|---|---|---|
| Cohort A (366 pts) | Cohort B (506 pts) | ||
| Surgery | |||
| Conservative | 214 (58.5) | 341 (67.4) | 0.007 |
| Radical | 152 (41.5) | 165 (32.6) | |
| Chemotherapy regimens | |||
| Anthracyclines-based | 188 (51.4) | 112 (22.1) | <0.0001 |
| Taxanes-based | 13 (3.6) | 61 (12.1) | |
| Anthracyclines and Taxanes-based | 74 (20.2) | 316 (62.5) | |
| No anthracyclines and No taxanes–based | 91 (24.9) | 17 (3.4) | |
| Cycles of chemotherapy | |||
| <6 | 64 (17.5) | 78 (15.4) | 0.24 |
| ≥6 | 261 (71.3) | 396 (78.3) | |
| Unknown | 41 (11.2) | 32 (6.3) | |
| Radiotherapy | |||
| Yes | 235 (64.2) | 373 (73.7) | 0.003 |
| Not | 131 (35.8) | 133 (26.3) | |
| Hormonal therapy | |||
| Yes | 332 (90.7) | 470 (92.9) | 0.24 |
| Not | 34 (9.3) | 36 (7.1) | |
Abbreviations: Pts, patients